Trials / Conditions / ALCL
ALCL
3 registered clinical trials studyying ALCL.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Crizotinib Continuation Clinical Study NCT05160922 | Pfizer | Phase 4 |
| Withdrawn | CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PT NCT04021082 | Portola Pharmaceuticals | Phase 2 / Phase 3 |
| Completed | Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL NCT02902874 | Gustave Roussy, Cancer Campus, Grand Paris | N/A |